• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能性白血病相关抗原特异性记忆性CD8 + T细胞存在于健康个体以及慢性粒细胞白血病患者干细胞移植前后。

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

作者信息

Rezvani Katayoun, Grube Matthias, Brenchley Jason M, Sconocchia Giuseppe, Fujiwara Hiroshi, Price David A, Gostick Emma, Yamada Ko, Melenhorst Jan, Childs Richard, Hensel Nancy, Douek Daniel C, Barrett A John

机构信息

National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Blood. 2003 Oct 15;102(8):2892-900. doi: 10.1182/blood-2003-01-0150. Epub 2003 Jun 26.

DOI:10.1182/blood-2003-01-0150
PMID:12829610
Abstract

Antigens implicated in the graft-versus-leukemia (GVL) effect in chronic myeloid leukemia (CML) include WT1, PR1, and BCR-ABL. To detect very low frequencies of these antigen-specific CD8+ T cells, we used quantitative polymerase chain reaction (qPCR) to measure interferon-gamma (IFN-gamma) mRNA production by peptide-pulsed CD8+ T cells from HLA-A*0201+ healthy volunteers and from patients with CML before and after allogeneic stem cell transplantation (SCT). Parallel assays using cytomegalovirus (CMV) pp65 tetramers demonstrated the IFN-gamma copy number to be linearly related to the frequency of tetramer-binding T cells, sensitive to frequencies of 1 responding CD8+ T cell/100 000 CD8+ T cells. Responses to WT1 and PR1 but not BCR-ABL were detected in 10 of 18 healthy donors. Responses to WT1, PR1, or BCR-ABL were observed in 9 of 14 patients with CML before SCT and 5 of 6 after SCT, often to multiple epitopes. Responses were higher in patients with CML compared with healthy donors and highest after SCT. These antigen-specific CD8+ T cells comprised central memory (CD45RO+CD27+CD57-) and effector memory (CD45RO-CD27-CD57+) T cells. In conclusion, leukemia-reactive CD8+ T cells derive from memory T cells and occur at low frequencies in healthy individuals and at higher frequencies in patients with CML. The increased response in patients after SCT suggests a quantitative explanation for the greater effect of allogeneic SCT.

摘要

慢性髓性白血病(CML)中与移植物抗白血病(GVL)效应相关的抗原包括WT1、PR1和BCR-ABL。为了检测这些抗原特异性CD8⁺ T细胞的极低频率,我们使用定量聚合酶链反应(qPCR)来测量来自HLA-A*0201⁺健康志愿者以及异基因干细胞移植(SCT)前后的CML患者的肽脉冲CD8⁺ T细胞产生的干扰素-γ(IFN-γ)mRNA。使用巨细胞病毒(CMV)pp65四聚体的平行检测表明,IFN-γ拷贝数与四聚体结合T细胞的频率呈线性相关,对1个反应性CD8⁺ T细胞/100 000个CD8⁺ T细胞的频率敏感。在18名健康供者中的10名中检测到对WT1和PR1而非BCR-ABL的反应。在14名SCT前的CML患者中有9名以及SCT后的6名患者中有5名观察到对WT1、PR1或BCR-ABL的反应,通常针对多个表位。CML患者的反应高于健康供者,且在SCT后最高。这些抗原特异性CD8⁺ T细胞包括中枢记忆(CD45RO⁺CD27⁺CD57⁻)和效应记忆(CD45RO⁻CD27⁻CD57⁺)T细胞。总之,白血病反应性CD8⁺ T细胞源自记忆T细胞,在健康个体中频率较低,在CML患者中频率较高。SCT后患者反应的增加为异基因SCT的更大效应提供了定量解释。

相似文献

1
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.功能性白血病相关抗原特异性记忆性CD8 + T细胞存在于健康个体以及慢性粒细胞白血病患者干细胞移植前后。
Blood. 2003 Oct 15;102(8):2892-900. doi: 10.1182/blood-2003-01-0150. Epub 2003 Jun 26.
2
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.急性淋巴细胞白血病异基因干细胞移植后,与可检测到的肾母细胞瘤-1特异性T淋巴细胞相关的移植物抗白血病效应。
Blood. 2007 Sep 15;110(6):1924-32. doi: 10.1182/blood-2007-03-076844. Epub 2007 May 15.
3
Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后慢性髓性白血病患者中 Wilms 瘤 1 蛋白特异性细胞毒性 T 淋巴细胞的移植物抗白血病效应。
Chin Med J (Engl). 2010 Apr 5;123(7):912-6.
4
The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.透明质酸介导的运动受体在健康供体和异基因造血干细胞移植后的慢性髓性白血病患者中诱导特异性CD8 + T细胞反应。
Int J Oncol. 2007 May;30(5):1119-27.
5
Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy.慢性髓性白血病患者多表位肿瘤特异性CD8 T细胞的体外特性:对疫苗开发和过继性细胞免疫治疗的意义
J Immunol. 2005 Jun 15;174(12):8210-8. doi: 10.4049/jimmunol.174.12.8210.
6
Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity.通过干细胞移植将PR1特异性T细胞克隆从供体转移至受体,并与移植物抗白血病活性相关联。
Cytotherapy. 2007;9(3):245-51. doi: 10.1080/14653240701218524.
7
Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.异基因造血干细胞移植治疗慢性髓性白血病的疗效改善与 BMI-1 表达水平升高和对 BMI-1 蛋白的免疫应答有关。
Leukemia. 2011 Apr;25(4):629-37. doi: 10.1038/leu.2010.325. Epub 2011 Jan 21.
8
Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia.树突状细胞可刺激bcr-abl特异性CD8+ T细胞的扩增,这些T细胞对慢性髓性白血病患者的白血病细胞具有细胞毒性活性。
Blood. 1998 Feb 1;91(3):977-83.
9
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.PR1-人白细胞抗原A2四聚体可用于从健康供体中分离出能选择性裂解慢性粒细胞白血病的低频细胞毒性T淋巴细胞。
Cancer Res. 1999 Jun 1;59(11):2675-81.
10
Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.慢性髓性白血病细胞表达引发特异性CD8 + T细胞反应的肿瘤相关抗原,且缺乏共刺激分子。
Exp Hematol. 2006 Dec;34(12):1709-19. doi: 10.1016/j.exphem.2006.07.009.

引用本文的文献

1
Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.对急性髓系白血病(AML)患者中威尔姆斯瘤蛋白1特异性T细胞受体库的分析发现,缓解期患者的多样性高于复发期患者。
Ann Hematol. 2025 Jan;104(1):317-333. doi: 10.1007/s00277-024-05919-1. Epub 2024 Sep 11.
2
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.免疫疗法成为急性髓系白血病治疗的转折点。
Cancers (Basel). 2021 Dec 13;13(24):6246. doi: 10.3390/cancers13246246.
3
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells.
表达 Tnfrsf4 的调节性 T 细胞促进慢性髓性白血病干细胞的免疫逃逸。
JCI Insight. 2021 Dec 8;6(23):e151797. doi: 10.1172/jci.insight.151797.
4
Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies.鉴定黑色素瘤肽中新型 HLA 限制性优先表达抗原,以促进现成的肿瘤相关抗原特异性 T 细胞治疗。
Cytotherapy. 2021 Aug;23(8):694-703. doi: 10.1016/j.jcyt.2021.03.001. Epub 2021 Apr 5.
5
T cell optimization for graft-versus-leukemia responses.T 细胞优化移植物抗白血病反应。
JCI Insight. 2020 May 7;5(9):134939. doi: 10.1172/jci.insight.134939.
6
T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies.T 细胞免疫疗法针对血液系统恶性肿瘤的组织相容性和肿瘤抗原。
Front Immunol. 2020 Feb 21;11:276. doi: 10.3389/fimmu.2020.00276. eCollection 2020.
7
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML).嵌合抗原受体(CAR)T细胞疗法治疗急性髓系白血病(AML)。
J Clin Med. 2019 Feb 6;8(2):200. doi: 10.3390/jcm8020200.
8
Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy.抑制血红素加氧酶-1 活性可增强癌症免疫治疗中 Wilms 肿瘤-1 特异性 T 细胞反应。
Int J Mol Sci. 2019 Jan 23;20(3):482. doi: 10.3390/ijms20030482.
9
Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells.通过用同种异体刺激细胞刺激白血病CD3 +细胞诱导抗白血病反应。
Exp Hematol Oncol. 2018 Oct 4;7:25. doi: 10.1186/s40164-018-0118-5. eCollection 2018.
10
Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response.生成表达 TCR 的先天淋巴样辅助细胞,诱导细胞毒性 T 细胞介导的抗白血病细胞反应。
Stem Cell Reports. 2018 Jun 5;10(6):1935-1946. doi: 10.1016/j.stemcr.2018.04.025. Epub 2018 May 24.